Tradestie Institutional Equity Comparison Engine
ACTU vs SABA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SABA Overall Edge
SABA Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Saba Capital Income & Opportunities Fund II (SABA) driven by superior Momentum & Technical, Options & Structure while ACTU counters with relative strength in Growth & Margin. Fundamentally, ACTU trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SABA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACTU sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against SABA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ACTU N/M vs SABA N/M Fwd P/E
Growth & Margin Winner
ACTU
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
SABA
1Y -96.2% vs -16.0% ยท 52W Pos 1% vs 4%
Options & Structure Winner
SABA
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
ACTU
NASDAQ
Actuate Therapeutics, Inc. Common stock
Pharmaceutical Preparations
$0.23
+5.38% 1D
Market Cap
$12.9M
1M Return
-56.35%
1Y Return
-96.15%
Forward P/E
N/M
Unified AI Score
35.1 / 100
SELL
Tech 25.0
Fund 37.0
Flow 50.0
Mom 49.0
SABA
NYSE
Saba Capital Income & Opportunities Fund II
Institutional Equity
$7.33
-0.27% 1D
Market Cap
$251.8M
1M Return
-3.68%
1Y Return
-16.04%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 38.0
Fund 55.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ACTU -96.15%
SABA -16.04%
Spread: +80.11 pp (SABA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ACTU TTM Op. Margin: 0.0%
SABA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACTU vs SABA. Trailing 12-month operating profitability (ACTU 0.0% vs SABA N/A) and valuation multiples (ACTU N/M vs SABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACTU | SABA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.9M | $251.8M | Larger Scale | SABA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | ACTU |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | ACTU |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ACTU |
| Return on Equity (ROE) Capital Efficiency | -553.8% | N/A | Higher ROE | ACTU |
| 52-Week Range Position Momentum | 1% ($0โ$8) | 4% ($7โ$9) | Stronger Trend | SABA |
| Beta / 30D Volatility Risk Regime | 1.64ฮฒ ยท 114% Vol | 0.37ฮฒ ยท 13% Vol | Lower Realized Risk | SABA |
| Unified Institutional Score Composite Signal | 35.1 / 100 (SELL) | 44.2 / 100 (HOLD) | Higher Composite | SABA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ACTU vs SABA Buy Guide
ACTU
BREAKDOWN
136d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SABA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ACTU nor SABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.